Carl Zeiss Meditec has reported a 10 percent year-on-year increase at constant exchange rates in sales of ophthalmic devices to €1,027 million for the first nine months of its current fiscal year. The division’s growth was once again driven by recurring revenue from consumables, implants and services while sales of ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
To continue reading this article register now.